Aug 13, 2020
Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
May 04, 2020
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Apr 23, 2020
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek(TM) Liquid Biopsy Technology
Mar 02, 2020
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference
Feb 12, 2020
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
Dec 16, 2019
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
Dec 13, 2019
Anixa Biosciences to Host Conference Call to Discuss Plans for 2020
Dec 13, 2019
Anixa Biosciences Provides Update on CAR-T Program
Nov 22, 2019
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
Nov 20, 2019
Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek(TM) Prostate Cancer Study
Nov 07, 2019
Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer
Nov 05, 2019
Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine
Oct 25, 2019
Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate Cancer Study
Oct 22, 2019
Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)
Oct 15, 2019
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
Sep 23, 2019
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek(TM) Prostate Cancer Study
Sep 16, 2019
Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree
Aug 26, 2019
Anixa Biosciences to Present at Two Upcoming Investor Conferences
Jul 24, 2019
Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology
Jul 17, 2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology